PDLIM7 and neoplasm: Due to urgent need for specific and sensitive tumor markers for the early diagnosis and treatment response prediction of NPC, this study has a particular interest in developing a qPCR assay for early diagnosis and treatment response prediction of NPC patients based on detection of LMP1 30 bp deletion genetic biomarker.